Pay in 4 interest-free payments of $7.22 Learn more
Ships within 48 hours · Estimated delivery Sep 5 - Sep 10
At therapeutic doses, GLP-1 drugs cross the blood-brain barrier and dampen dopamine signaling in the brains core reward center, making addictive substances less rewarding
Available at: [accessed March 2026]. Wegovy (semaglutide) injection US prescribing information, NDA 215256
Successful discontinuation requires ensuring the lifestyle modifications around nutrition, movement, stress management, and sleep established during treatment can be sustained without medication support
(2024) and Zhou and Tian (2018) emphasized mitochondrial dysfunction as a pathophysiological driver
Our published research found that members taking semaglutide alongside this support achieved an average of 19.1% weight loss at 12 months, with 77.7% reaching at least 10% weight loss
